Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03669575
Other study ID # 16-1575
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2017
Est. completion date October 1, 2019

Study information

Verified date October 2019
Source Bastyr University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to determine whether the palmitoleic acid supplementation can reduce the serum inflammatory biomarkers and low quality of life scores due to musculoskeletal discomfort. The study design is a 2-arm placebo-controlled double blind crossover trial. The randomized sequence of a single crossover is divided into 1:1 and each supplementation is three weeks with no washout in between.


Description:

The purpose of the study is to investigate whether or not the supplementation of a particular omega-7 fatty acid decreases the serum biomarkers of inflammation, i.e. highly sensitive C-reactive protein, TNF-alpha and IL-6 of participants who have been experiencing decreased quality of life (QOL) and having elevated these serum markers. The study is placebo-controlled and conducted in a double blinded manner. Participants will be crossed over on supplements (active and placebo) in a random sequence. The total length of a trial is six weeks in which the participants will be asked to maintain stable diet. The baseline blood draw, physical exam, range of motion, QOL and dietary assessment and taking vitals are performed. After the blood test results and/or QOL assessment confirm the eligibility, three weeks supply of the investigational supplement will be mailed or picked up in person. The supplementation is one gel-capusule a day for three weeks. At the end of three weeks, another blood draw, physical exam, range of motion, and QOL assessment are conducted; then the other investigational supplement will be provided. The assessment of the second supplement will occur after another three-week mark. If no adverse reaction is observed and there is no concerns, the participant will be exited from the study.

The goal of enrollment is 50 participants who are between 18 to 99 years old with decreased quality of life and potentially elevated serum markers of inflammation. Volunteers will be randomized by a block of four so at any given moment, one group does not exceed more than three participants. The study takes place at Kenmore campus.


Recruitment information / eligibility

Status Completed
Enrollment 56
Est. completion date October 1, 2019
Est. primary completion date June 30, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: (any of the below)

- baseline CRP 1.0 mg/L or higher

- > 3 months (chronic) musculoskeletal pain/discomfort, which the participant is able to monitor during the course of trial (6 weeks)

Exclusion Criteria:

- Taking narcotic or opioid pain medication

- Unable to monitor NSAID or OTC pain medication quantity

- Unable to visit Kenmore Washington Clinical Research Center for three times

- Objection from his/her primary care doctor

- Employee or family member of Barlines Organics

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
omega 7
Three weeks omega 7 fatty acid nutritional supplement, approximately 900 mg/day
Placebo
Three weeks placebo fatty acids approximately 900 mg/day which does not contain omega 7

Locations

Country Name City State
United States Bastyr University Clinical Research Center Kenmore Washington

Sponsors (1)

Lead Sponsor Collaborator
Bastyr University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary CRP (serum) Quantification of the serum hsCRP level during active supplement 3 weeks
Primary Pain/discomfort (self-assessment from 1 - 10) The self-reported level of the musculoskeletal pain/discomfort during active supplement 3 weeks
Secondary Omega 7 (plasma) Quantification of the plasma palmitolenic acid (major omega 7 fatty acid) level during the active supplementation 3 weeks
Secondary IL-6 (plasma) Quantification of the plasma IL-6 level during the active supplementation 3 weeks
Secondary TNFalpha (plasma) Quantification of the plasma TNFalpha level during the active supplementation 3 weeks
See also
  Status Clinical Trial Phase
Completed NCT05046249 - Swiss Chiropractic Cohort (Swiss ChiCo) Study: A Nationwide Practice-Based Research Network Project
Completed NCT04053686 - An Intervention to Reduce Prolonged Sitting in Police Staff N/A
Completed NCT05071469 - Comparison of Two Different Treatment Methods N/A
Recruiting NCT04285112 - SPRINT: Signature for Pain Recovery IN Teens
Enrolling by invitation NCT05946018 - Physiatrist Ergonomic Intervention on Work Related Musculoskeletal Pain in Surgeons N/A
Active, not recruiting NCT03537573 - Provider-Targeted Behavioral Interventions to Prevent Unsafe Opioid Prescribing for Acute Pain in Primary Care N/A
Completed NCT02920853 - Enhanced Biofeedback for Musculoskeletal Pain N/A
Completed NCT02438384 - Patient Education to Improve Pain Management in Older Adults With Acute Musculoskeletal Pain: A Pilot Randomized Trial N/A
Active, not recruiting NCT02378519 - Interactive Web-based Program and CBT-coaching With Physiotherapy for Patients With Chronic Musculoskeletal Pain N/A
Enrolling by invitation NCT02485795 - Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management N/A
Completed NCT02121587 - Osteopathy, Mindfulness and Acceptance-based Programme for Patients With Persistent Pain N/A
Terminated NCT01992770 - A Stepped-care Model of Tailored Behavioural Medicine Pain Intervention in Primary Care N/A
Completed NCT04575974 - Lifestyle in Adolescence and Persistent Musculoskeletal Pain in Young Adulthood
Recruiting NCT05220202 - MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression N/A
Completed NCT04029285 - Exergaming Experience of Older People With Chronic Musculoskeletal Pain N/A
Completed NCT06069011 - Direct Access Physiotherapy in the Pediatric Emergency Department N/A
Completed NCT04704375 - Effects of Osteopathic Manipulative Treatment and Bio Electro-Magnetic Regulation Therapy on Low Back Pain in Adults. N/A
Completed NCT04498663 - The Pain & Stress Interview Study for People With Chronic Pain N/A
Completed NCT04009369 - Impacts of Physiotherapy Services in a Quebec Emergency Department N/A
Not yet recruiting NCT06119698 - Improving Health for Older Adults With Pain Through Engagement N/A